Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe is a dataset published in Wellcome Open Research (2022). On theSindex it has a DataRank of 0.193, placing it in the top 65.5% of the data-sharing corpus. It has been cited 2 times, with 2 citing works in its 1-hop citation network. Its calibrated FAIR score is 54/100.
Ranks in the top 65% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The identifier given is a web URL (https://data.ohdsi.org/...), which is not a persistent identifier scheme (no DOI, Handle, ARK, URN, or repository accession). [majority verdict 'partial' (3/5 passes agreed)]
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The holder named is a website (data.ohdsi.org), not a recognised repository from the list (e.g., GEO, Zenodo, Dryad) or a re3data-registered archive. [majority verdict 'partial' (3/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The dataset's identifier appears only in the body text (Data availability section), not in the reference list. [majority verdict 'partial' (3/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“Underlying data Raw data from each database cannot be shared due to data privacy and governance requirements but raw data could be accessed according to the terms and conditions of each data source. The data source information including the terms and conditions for data access can be found in Table 8 . Analyses were performed locally in compliance with all applicable data privacy laws. All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/). All analytic code and result sets have been made available (https://github.com/ohdsi-studies/Covid19Characterization - Charybdis). Archived analysis code as at time of publication: https://doi.org/10.5281/zenodo.5779264. Code is available under the terms of the Apache License 2.0.”— not found in the paper; verdict downgraded
The statement points to a public repository URL for the aggregate data, which is a repository record (Colavizza category 3). [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (4/5 passes agreed)]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“This project contains the following extended data: • Supplementary Table S1. Age and gender distribution of hospitalized COVID-19 patients with COPD. • Supplementary Table S2. Age and gender distribution of diagnosed COVID-19 patients with COPD. • Supplementary Table S3 . Prevalence of treatments in patients with COPD in the 30 days before COVID-19 diagnosis. • Supplementary Table S4 . Prevalence of outcomes in diagnosed COVID-19 patients with COPD with 95%CI. • Supplementary Figure S1 . Flow chart showing database selection. • Supplementary Figure S2 . Prevalence of age and gender among COPD patients with COVID-19 who have been diagnosed and hospitalized. • Supplementary Figure S3 . Comparison of characteristics between COPD patients with COVID-19 in the diagnosed and hospitalized cohorts by SMD. • Appendix 1 . Overview of Data Sources Screened for Eligibility and Contributing Results • Appendix 2 . Definitions and codes used to identify COVID-19 • Appendix 3 . Definitions and codes used to identify COPD patients”— not found in the paper; verdict downgraded
The paper provides an itemised list of the supplementary files (extended data) contained in the Zenodo deposit. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (3/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The aggregate data are stated to be freely available without any precondition.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The paper labels the data as 'freely available' which is a natural-language equivalent of open access. [majority verdict 'yes' (4/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“Raw data from each database cannot be shared due to data privacy and governance requirements but raw data could be accessed according to the terms and conditions of each data source.”
No institutional gatekeeper (e.g., a specific repository, committee, or agreement) is named for the sensitive raw data; only a vague reference to each data source's terms is given.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
“All aggregate data has been made freely available for public inquiry (https://data.ohdsi.org/Covid19CharacterizationCharybdis/).”
The paper states when the data are available (freely available now) but makes no commitment to how long they will persist. [majority verdict 'partial' (4/5 passes agreed)]
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released aggregate data.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
“All data for were standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) 8,9.”
The paper names the OMOP Common Data Model and SNOMED CT codes, both of which are community data/metadata standards registered in FAIRsharing.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
No persistent identifier for an external resource (beyond routine references) is provided for the data's dependencies. [majority verdict 'no' (4/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
“Data are available under the terms of the Creative Commons Attribution 4.0 International Public License (Attribution 4.0 International).”— not found in the paper; verdict downgraded
The paper names an open standard license (CC BY 4.0) for the data. [downgraded to 'partial' — no verifiable quote from the paper]
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
No version token or date is stated for the dataset itself; the code archive has a version, but the data do not. [majority verdict 'no' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“All analytic code and result sets have been made available (https://github.com/ohdsi-studies/Covid19Characterization - Charybdis). Archived analysis code as at time of publication: https://doi.org/10.5281/zenodo.5779264.”— not found in the paper; verdict downgraded
A machine-resolvable locator (GitHub URL and Zenodo DOI) is provided for the code. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (4/5 passes agreed)]
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968.”
The paper gives specific grant/agreement numbers for funding.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
The paper does not name specific instruments, kits, or software used to produce the data (only generic analysis methods). [majority verdict 'no' (2/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“Appendix 2. Definitions and codes used to identify COVID-19”— not found in the paper; verdict downgraded
The variable/code definitions are provided inside the article (appendices), not as a separate documentation object shipped with the data. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0.0278
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
Wellcome Trust
Grant: 214588
Approaches for Creating Clinical Evidence of treatment effects in routine Populations excluded from Trials (ACCEPT)
FWCI
0.19
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals